These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Utility of fetal echocardiography in postnatal management of infants with prenatally diagnosed congenital heart disease. Berkley EM; Goens MB; Karr S; Rappaport V Prenat Diagn; 2009 Jul; 29(7):654-8. PubMed ID: 19340841 [TBL] [Abstract][Full Text] [Related]
5. Health and developmental outcome of children following prenatal diagnosis of confined placental mosaicism. Amor DJ; Neo WT; Waters E; Heussler H; Pertile M; Halliday J Prenat Diagn; 2006 May; 26(5):443-8. PubMed ID: 16548008 [TBL] [Abstract][Full Text] [Related]
6. Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia. Crowley A; Martin C; Fitzpatrick P; Sheils O; O'Herlihy C; O'Leary JJ; Byrne BM Prenat Diagn; 2007 Feb; 27(2):174-9. PubMed ID: 17191257 [TBL] [Abstract][Full Text] [Related]
7. Outcome of prenatally diagnosed congenital heart disease: an update. Brick DH; Allan LD Pediatr Cardiol; 2002; 23(4):449-53. PubMed ID: 12170364 [TBL] [Abstract][Full Text] [Related]
8. Congenital heart disease among spontaneous abortuses and stillborn fetuses: prevalence and associations. Chinn A; Fitzsimmons J; Shepard TH; Fantel AG Teratology; 1989 Nov; 40(5):475-82. PubMed ID: 2623637 [TBL] [Abstract][Full Text] [Related]
9. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of prenatal screening for congenital heart disease: assessment in a jurisdiction with universal access to health care. Trines J; Fruitman D; Zuo KJ; Smallhorn JF; Hornberger LK; Mackie AS Can J Cardiol; 2013 Jul; 29(7):879-85. PubMed ID: 23725863 [TBL] [Abstract][Full Text] [Related]
11. Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre. Clur SA; Mathijssen IB; Pajkrt E; Cook A; Laurini RN; Ottenkamp J; Bilardo CM Prenat Diagn; 2008 Apr; 28(4):347-54. PubMed ID: 18382996 [TBL] [Abstract][Full Text] [Related]
12. Abnormal multiple marker screens are associated with adverse perinatal outcomes in cases of intrauterine growth restriction. Ilagan JG; Stamilio DM; Ural SH; Macones GA; Odibo AO Am J Obstet Gynecol; 2004 Oct; 191(4):1465-9. PubMed ID: 15507984 [TBL] [Abstract][Full Text] [Related]
14. [Prevalence and distribution of congenital cardiopathy at birth and in pregnancy termination: impact of prenatal diagnosis in 4 years of experience]. Vimercati A; Greco P; Di Fazio F; Loizzi V; Balducci G; Caruso G; Ingravallo G; Selvaggi L Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():487-92. PubMed ID: 11424794 [TBL] [Abstract][Full Text] [Related]
15. Intrapartum fetal heart rate monitoring in cases of congenital heart disease. Ueda K; Ikeda T; Iwanaga N; Katsuragi S; Yamanaka K; Neki R; Yoshimatsu J; Shiraishi I Am J Obstet Gynecol; 2009 Jul; 201(1):64.e1-6. PubMed ID: 19481721 [TBL] [Abstract][Full Text] [Related]
18. Gross morphological changes of placentas associated with intrauterine growth restriction of fetuses: a case control study. Biswas S; Ghosh SK Early Hum Dev; 2008 Jun; 84(6):357-62. PubMed ID: 18093757 [TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of outcome of pregnancy in women with congenital heart disease: single-centre experience from North India. Aggarwal N; Suri V; Kaur H; Chopra S; Rohila M; Vijayvergiya R Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):376-81. PubMed ID: 19694691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]